FT
RGEN icon

Fiduciary Trust’s Repligen RGEN Stock Holding History

Fiduciary Trust’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,699
Closed -$312K – 646
2024
Q1 		$312K Sell
1,699
-1
-0.1% -$190 ﹤0.01% 551
2023
Q4 		$306K Hold
1,700
– – 0.01% 533
2023
Q3 		$270K Sell
1,700
-650
-28% -$106K ﹤0.01% 546
2023
Q2 		$332K Sell
2,350
-17
-0.7% -$2.73K 0.01% 524
2023
Q1 		$399K Hold
2,367
– – 0.01% 485
2022
Q4 		$401K Buy
2,367
+17
+0.7% +$3.08K 0.01% 489
2022
Q3 		$440K Sell
2,350
-50
-2% -$10.5K 0.01% 449
2022
Q2 		$390K Hold
2,400
– – 0.01% 493
2022
Q1 		$451K Buy
2,400
+500
+26% +$95K 0.01% 489
2021
Q4 		$503K Sell
1,900
-100
-5% -$26.9K 0.01% 473
2021
Q3 		$578K Hold
2,000
– – 0.01% 444
2021
Q2 		$399K Hold
2,000
– – 0.01% 500
2021
Q1 		$389K Buy
+2,000
New +$410K 0.01% 492

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Fiduciary Trust's RGEN Position: Q2 2024 in Review

Fiduciary Trust sold out of Repligen (RGEN) in Q2 2024, closing a stake of 1,699 shares — an estimated $312K sold.

Fiduciary Trust first reported a position in RGEN in Q1 2021 and held it in 13 quarters. The position peaked at $578K in Q3 2021. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

  • Fiduciary Trust reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
  • Fiduciary Trust sold 1,699 Repligen shares in Q2 2024, an estimated $312K.
  • Fiduciary Trust first reported a position in Repligen in Q1 2021 and held it in 13 quarters.
  • Fiduciary Trust's Repligen position peaked at $578K in Q3 2021.
  • 455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on Fiduciary Trust's 13F filing for Q2 2024, filed 14 Aug 2024.